Tonix Pharmaceuticals Announces Accelerating Completion of Enrollment in Phase 2 UPLIFT Study of TNX-601 ER (Racemic Tianeptine) for Major Depressive Disorder: Topline Data Now Expected in Fourth Quarter 2023
July 26, 2023 16:05 ET
|
Tonix Pharmaceuticals Holding Corp.
Reallocating Resources to Development of Single Isomer TNX-4300 (Estianeptine) Estianeptine in Preclinical Development Has Demonstrated Key Activities Related to in vivo Novel Object Recognition and...
[Latest] Global Mitral Valve Disease Market Size/Share Worth USD 6.1 Billion by 2032 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 25, 2023 14:20 ET
|
Custom Market Insights
Austin, TX, USA, July 25, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Mitral Valve Disease Market Size, Trends and Insights By Treatment Type (Mitral...
Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement
July 24, 2023 07:30 ET
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage...
Tonix Pharmaceuticals Announces Data Supporting the Memory- and Cognition-Enhancing Effects of Racemic Tianeptine and (S)-Tianeptine, but not (R)-Tianeptine, in the In Vivo Rat Novel Object Recognition (NOR) Test
July 24, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
New Findings Support Development of Racemic Tianeptine and (S)-Tianeptine (Estianeptine) as First-in-Class Oral Therapies in Alzheimer’s Disease and Other Psychiatric and Neurodegenerative Conditions...
Biotech and Biopharma Executive Eliana Clark Joins Culture Biosciences’ Advisory Board
July 19, 2023 06:39 ET
|
Culture Biosciences
SAN FRANCISCO, July 19, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences is excited to welcome Eliana Clark, PhD, Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc., to...
Antibody Production Market to Surpass USD 30.7 billion in 2031, expanding at a CAGR of 7.8%: TMR Report
July 17, 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 17, 2023 (GLOBE NEWSWIRE) -- The global antibody production market is projected to flourish at a CAGR of 7.8% from 2021 to 2031. As per the report published...
Tonix Pharmaceuticals Announces Agreement and Initiation of Enrollment in Phase 2 Trial with the University of Washington to Study TNX-1900 (Potentiated Intranasal Oxytocin) for Social Anxiety Disorder
July 17, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company, today announced that the first participant has been enrolled in a...
EnteroBiotix appoints Elmar Schnee as Executive Chairman
July 17, 2023 03:00 ET
|
EnteroBiotix
GLASGOW, Scotland, July 17, 2023 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage company with the premier platform for full-spectrum microbiome therapeutics, today announced the...
Biotech Executive Beth Thompson-Webb Joins Culture Biosciences’ Board of Directors
July 13, 2023 06:33 ET
|
Culture Biosciences
BOSTON, July 13, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences has appointed Beth Thompson-Webb, Chief Commercial Officer at Virica Biotech, as Independent Director to the company’s Board of...
SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer
July 13, 2023 04:00 ET
|
SiSaf Ltd
GUILDFORD, England, July 13, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I....